Recruiting NA Macular Holes

New treatment option for Macular Holes

Official title Comparative Study of Decellularized Human Amniotic Membrane Hydrogel and Inverted Internal Limiting Membrane Flap in Idiopathic Large Macular Holes

ClinicalTrials.gov ID: NCT06433284

What this study is testing

What it's testing
The human amniotic membrane (hAM) patch, introduced by Rizzo et al. in 2018, showed a 100% anatomical success rate for large or failed macular holes over a 6-month follow-up.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • \>18 years old
  • idiopathic full thickness macular hole \> 400 micron of diameter
  • phakic or pseudophakic
  • absence of systemic adverse conditions

You likely can't join if

  • idiopathic full thickness macular hole \> 1,500 micron of diameter
  • traumatic macular holes
  • myopic macular holes,
  • concomitant retinal and other ocular disease
  • previous ocular surgery except cataract surgery

The study team makes the final eligibility decision.

Where it's taking place

  • Nakhon Si Thammarat, Thasala, Thailand

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Nakhon Si Thammarat, Thasala, Thailand. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.